SYNE1双相障碍风险位点中影响CPG2表达与蛋白功能的遗传变异
该研究聚焦双相障碍风险位点SYNE1中编码CPG2的区域,发现双相障碍患者尸脑CPG2蛋白水平显著低于对照、精神分裂症和抑郁症患者。研究识别出CPG2启动子区遗传变异负向影响基因表达,以及编码区错义SNP影响CPG2表达、定位和突触功能,将遗传变异与谷氨酸能突触功能障碍机制联系起来。
要点
- 双相障碍患者尸脑CPG2蛋白水平显著低于对照、精神分裂症和抑郁症患者。
- CPG2启动子区遗传变异负向影响基因表达。
- CPG2编码区错义SNP影响其表达、定位和突触功能。
核心结论
- SYNE1中CPG2区域的遗传变异通过影响CPG2表达和蛋白功能,与谷氨酸能突触功能障碍机制相关联,可能构成部分个体双相障碍易感性的基础。
研究设计与样本
- 研究比较双相障碍患者与对照、精神分裂症和抑郁症患者尸脑组织中CPG2蛋白水平,并识别CPG2启动子区和编码区遗传变异。
主要发现
- 双相障碍患者尸脑CPG2蛋白水平显著低于对照受试者,也低于精神分裂症和抑郁症患者。
- CPG2启动子区遗传变异负向影响基因表达。
- CPG2编码区错义单核苷酸多态性影响CPG2表达、定位和突触功能。
临床怎么用
- 提示CPG2蛋白水平及SYNE1 CPG2区域遗传变异可能作为双相障碍与其他重叠临床特征神经精神障碍鉴别诊断的潜在生物标志物方向。
局限性
- 原文未报告样本量、统计阈值或置信区间等定量细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bipolar disorder (BD) is a common mood disorder characterized by recurrent episodes of mania and depression. Both genetic and environmental factors have been implicated in BD etiology, but the biological underpinnings remain elusive. Recently, genome-wide association studies (GWAS) of neuropsychiatric disorders have identified a risk locus for BD containing the SYNE1 gene, a large gene encoding multiple proteins. The BD association signal spans, almost exclusively, the part of SYNE1 encoding CPG2, a brain-specific protein localized to excitatory postsynaptic sites, where it regulates glutamate receptor internalization. Here we show that CPG2 protein levels are significantly decreased in postmortem brain tissue from BD patients, as compared to control subjects, as well as schizophrenia and depression patients. We identify genetic variants within the postmortem brains that map to the CPG2 promoter region, and show that they negatively affect gene expression. We also identify missense single nucleotide polymorphisms (SNPs) in CPG2 coding regions that affect CPG2 expression, localization, and synaptic function. Our findings link genetic variation in the CPG2 region of SYNE1 with a mechanism for glutamatergic synapse dysfunction that could underlie susceptibility to BD in some individuals. Few GWAS hits in human genetics for neuropsychiatric disorders to date have afforded such mechanistic clues. Further, the potential for genetic distinction of susceptibility to BD from other neuropsychiatric disorders with overlapping clinical traits holds promise for improved diagnostics and treatment of this devastating illness.
引用
- Rathje M, Waxman H, Benoit M, et al. Genetic variants in the bipolar disorder risk locus SYNE1 that affect CPG2 expression and protein function. Mol Psychiatry. 2019. PMID: 30610203. doi:10.1038/s41380-018-0314-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。